Effect of nebulized eucalyptus on prevention of ventilator-associated pneumonia in ventilated patient
- Conditions
- ventilator-associated pneumonia.
- Registration Number
- IRCT20161014030294N3
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Obtaining the consent of the treating physician, presence of endotracheal tube, age 16 to 65 years, mechanical ventilation for at least 72 hours, no lung infection based on the clinical score of modified lung infection (MCPIS), no sensitivity to plant compounds, no Presence of sepsis, pulmonary thromboembolism, atelectasis, inflammatory diseases of the gastrointestinal tract, bile ducts and severe liver disease at the discretion of a specialist (based on physical examination and history taken from the patient).
Transfer of the patient from the ICU (for any reason) or death before the completion of the study, unwillingness of the patient's companions to continue the study, chest surgery, observation of complications due to eucalyptus fumigation such as urticaria, pruritus and skin rash, sudden changes in The patient's clinical condition or respiratory pattern, worsening of the patient's general condition, or decreased level of consciousness due to possible infection.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Type of microbial contamination of patients' lung secretions. Timepoint: Samples of endotracheal secretions for microbiological studies 72 hours, 7 days and 15 days after inhalation and when the patient is extubated. Method of measurement: Microbiological test.
- Secondary Outcome Measures
Name Time Method Incidence of possible complications. Timepoint: From the beginning of the intervention continuously. Method of measurement: observation.